Trial intelligence / Profile preview

Cyclosporin A Combined to Intravenous Thrombolysis in Stroke

NCT01527240Phase 2Completed

Sponsor
Hospices Civils de Lyon
Start
Oct 2009
Primary completion
Oct 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in ischemic stroke comparing Ciclosporin A with Placebo (2 arms). Primary endpoint: Volume of cerebral infarction at Day 30. Started Oct 2009; status: completed.

02

Drugs

cyclosporine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT01527240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01527240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call